MedPath
NMPA Approval

Telmisartan and Amlodipine Tablets

国药准字H20249563

December 1, 2024

Drug Information

替米沙坦氨氯地平片

片剂

每片含替米沙坦80mg与苯磺酸氨氯地平5mg(以氨氯地平计)

化学药品

December 1, 2024

Company Information

Applicant Company

南京市江宁区高新园龙眠大道578号

Manufacturing Company

连云港市经济技术开发区泰山北路58号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替米沙坦氨氯地平片 - NMPA 批准文号 | MedPath